[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353577-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-353577-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","novel-homozygous-variants-in-cidec-and-wrn-in-a-young-female-with-lipodystrophy-and-thyroid-cancer","Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer","","Autosomal recessive familial partial lipodystrophy type 5 (FPLD5) is linked to homozygous CIDEC variants. The report describes an 18-year-old Hispanic female with familial partial lipodystrophy and features including hirsutism, acanthosis nigricans, and pronounced insulin resistance. Whole-exome sequencing identified extremely rare homozygous variants in CIDEC and a novel homozygous WRN variant. At 17 years, she developed invasive papillary thyroid carcinoma. Findings support CIDEC’s association with the FPL phenotype and underscore rare co-occurrence with thyroid cancer, suggesting surveillance for metabolic and WRN-associated neoplastic and premature-aging features.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/novel-homozygous-variants-in-cidec-and-wrn-in-a-young-female-with-lipodystrophy-and-thyroid-cancer/353577/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/novel-homozygous-variants-in-cidec-and-wrn-in-a-young-female-with-lipodystrophy-and-thyroid-cancer/353577.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What genetic variants were identified in the patient?","Question",{"text":62,"@type":63},"Whole-exome sequencing detected a homozygous CIDEC variant and a novel homozygous WRN variant.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Which clinical features were present alongside familial partial lipodystrophy?",{"text":67,"@type":63},"The patient had lipodystrophy with hirsutism, acanthosis nigricans, and marked insulin resistance.",{"name":69,"@type":60,"acceptedAnswer":70},"How did the thyroid cancer influence the significance of the report?",{"text":71,"@type":63},"The patient developed invasive papillary thyroid carcinoma at age 17, highlighting an extremely rare co-occurrence of FPLD5 with thyroid cancer and informing surveillance considerations.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},353577,1790765747,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Case Report  \nNovel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer  \nNivedita Patni 1, Chao Xing 2,3,4, Chun-Yuan Huang 2, Rebecca J. Brown 5 and Abhimanyu Garg 6, *  \nAcademic Editors: Francesca Oliviero and Anna Lisa Giuliani  \nReceived: 17 November 2025  \nRevised: 21 December 2025  \nAccepted: 30 December 2025  \nPublished: 8 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Division of Endocrinology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA; [nivedita.patni@utsouthwestern.edu](nivedita.patni@utsouthwestern.edu)  \n2 McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA; [chao.xing@utsouthwestern.edu](chao.xing@utsouthwestern.edu) (C.X.); [chunyuanh@mail.smu.edu](chunyuanh@mail.smu.edu) (C.-Y.H.)  \n3 Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX 75390, USA  \n4 O’Donnell School of Public Health, UT Southwestern Medical Center, Dallas, TX 75390, USA  \n5 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA; [brownrebecca@niddk.nih.gov](brownrebecca@niddk.nih.gov)  \n6 The Section of Nutrition and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine and the Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX 75390, USA  \n* Correspondence: [abhimanyu.garg@utsouthwestern.edu](abhimanyu.garg@utsouthwestern.edu)  \nAbstract  \nAutosomal recessive familial partial lipodystrophy type 5 (FPLD5) due to a homozygous NP_ 001186481.1; p.E186* CIDEC variant has previously been reported in a 19-year-old female with diabetes mellitus, hypertriglyceridemia, and hepatic steatosis. Now, we report an 18-year-old Hispanic female who presented with FPL, along with hirsutism, acanthosis nigricans, and marked insulin resistance, and was found to have an extremely rare homozygous variant in CIDEC (NM_ 001199623.2:c.224G>T; NP_ 001186552.1; p.Ser75Ile) by whole exome sequencing. She also harbored a novel homozygous variant in WRN (NM_ 000553.4:c.1856T>G; NP_ 000544; p.Leu619Arg) . Both serine 75 of the CIDEC protein and leucine 619 of the WRN protein were well conserved across species. She developed an invasive papillary thyroid carcinoma at the age of 17 years. Our report confirms the previously reported association of the biallelic CIDEC variant with the FPL phenotype and also highlights the extremely rare possibility of co-occurrence of FPLD5 with thyroid cancer, a clinical feature of Werner syndrome. Thus, our patient may not only need surveillance for the metabolic complications of FPLD5, such as diabetes, hypertriglyceridemia, and hepatic steatosis, but also for WRN-associated neoplasms and features of premature aging.  \nKeywords: partial lipodystrophy; papillary thyroid carcinoma; WRN; CIDEC; FSP27  \n1. Introduction  \nAutosomal recessive familial partial lipodystrophy (FPL) syndromes due to biallelic variants in the CIDEC, LIPE, and PCYT1A genes have only been reported in a small number of patients [1–4] . For example, only one 19-year-old Ecuadorian female with FPL harboringa biallelic homozygous null variant (NP_001186481.1; p.E186*) in Cell death-inducing DFFA-like effector C (CIDEC) has been reported previously [4] . She had childhood-onset acanthosis nigricans, hepatic steatosis, extreme hypertriglyceridemia, uncontrolled diabetes mellitus, and, on follow-up, developed microalbuminuria and hypertension [4] . However, all these phenotypic features of this patient could not be conclusively attributed to the CIDEC variant [4] . Here, we provide further evidence for CIDEC as the locus of  \nautosomal–recessive FPL by reporting another young female harboring a homozygous CIDEC missense variant, who, i","cbCaimmKygk6P3Y3","https://ap.wps.com/l/cbCaimmKygk6P3Y3","pdf",1252650,11,"English","# Introduction\n# Case Report","[{\"question\":\"What genetic variants were identified in the patient?\",\"answer\":\"Whole-exome sequencing detected a homozygous CIDEC variant and a novel homozygous WRN variant.\"},{\"question\":\"Which clinical features were present alongside familial partial lipodystrophy?\",\"answer\":\"The patient had lipodystrophy with hirsutism, acanthosis nigricans, and marked insulin resistance.\"},{\"question\":\"How did the thyroid cancer influence the significance of the report?\",\"answer\":\"The patient developed invasive papillary thyroid carcinoma at age 17, highlighting an extremely rare co-occurrence of FPLD5 with thyroid cancer and informing surveillance considerations.\"}]","Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer | PDF",1790106127,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/240ccacd45fcb0e7a10cd5beff335cb1.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d288a7e532b44e18bac52b9603f2233.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/385f6ad7d897643c2fb41a99b2fdfe47.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/372f4baa4fdab0a2a302c509d0cee1de.webp",980,1385]